Human T-cell leukemia virus (HTLV-1) is a lymphotropic retrovirus associated to adult T cell leukemia (ATL) and to non-neoplastic inflammatory conditions affecting the central nervous system, lung or skin. The inflammatory disorders associated to HTLV-1 are mediated by different proinflammatory cytokines as IL-1α, IL-6, TNF-α. The release and the role of IL-17 is still debated. Aims of this study were to analyze IL-17 induction by HTLV-1 infection and to determine whether resveratrol (RES) is able to down regulate the pathway of cytokines production either in HTLV-1 chronically infected MT-2 cell line or in human CD4+ cells infected in vitro with HTLV-1.

Fuggetta, M., Bordignon, V., Cottarelli, A., Macchi, B., Frezza, C., Cordiali Fei, P., et al. (2016). Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 35(1), 118-126 [10.1186/s13046-016-0398-8].

Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol

MACCHI, BEATRICE;
2016-01-01

Abstract

Human T-cell leukemia virus (HTLV-1) is a lymphotropic retrovirus associated to adult T cell leukemia (ATL) and to non-neoplastic inflammatory conditions affecting the central nervous system, lung or skin. The inflammatory disorders associated to HTLV-1 are mediated by different proinflammatory cytokines as IL-1α, IL-6, TNF-α. The release and the role of IL-17 is still debated. Aims of this study were to analyze IL-17 induction by HTLV-1 infection and to determine whether resveratrol (RES) is able to down regulate the pathway of cytokines production either in HTLV-1 chronically infected MT-2 cell line or in human CD4+ cells infected in vitro with HTLV-1.
2016
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/14 - FARMACOLOGIA
English
HTLV-1; Inflammatory cytokines; Resveratrol
Fuggetta, M., Bordignon, V., Cottarelli, A., Macchi, B., Frezza, C., Cordiali Fei, P., et al. (2016). Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 35(1), 118-126 [10.1186/s13046-016-0398-8].
Fuggetta, M; Bordignon, V; Cottarelli, A; Macchi, B; Frezza, C; Cordiali Fei, P; Ensoli, F; Ciafre, S; Marino Merlo, F; Mastino, A; Ravagnan, G
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
FuggettaJExpClinExpCancRes2016.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 920.24 kB
Formato Adobe PDF
920.24 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/159892
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 26
social impact